Literature DB >> 11820805

Sequence analysis of the entire mitochondrial genome in Parkinson's disease.

Cristofol Vives-Bauza1, Antoni L Andreu, Giovanni Manfredi, M Flint Beal, Bernd Janetzky, Thomas H Gruenewald, Michael T Lin.   

Abstract

The pathogenesis of Parkinson's disease (PD) is largely unknown. Indirect evidence suggests that mutations in mitochondrial DNA (mtDNA) might play a role, but previous studies have not consistently associated any specific mutations with PD. However, these studies have generally been confined to limited areas of the mitochondrial genome. We therefore sequenced the entire mitochondrial genome from substantia nigra of 8 PD and 9 control subjects. Several sequence variants were distributed differently between PD and control subjects, but all were previously reported polymorphisms. Several secondary LHON mutations were found, as well as a number of novel missense mutations, but all were rare and did not differ between PD and control subjects. Finally, PD and control subjects did not differ in the total number of all mutations, nor the total number of missense mutations. Thus, mtDNA involvement in PD, if any, is likely to be complex and should be reconsidered carefully. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11820805     DOI: 10.1006/bbrc.2002.6388

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  What is a 'novel' mtDNA mutation--and does 'novelty' really matter?

Authors:  Hans-Jürgen Bandelt; Antonio Salas; Claudio M Bravi
Journal:  J Hum Genet       Date:  2006-10-05       Impact factor: 3.172

Review 2.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 3.  The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?

Authors:  Hirokazu Fukui; Carlos T Moraes
Journal:  Trends Neurosci       Date:  2008-04-09       Impact factor: 13.837

Review 4.  The case for the continuing use of the revised Cambridge Reference Sequence (rCRS) and the standardization of notation in human mitochondrial DNA studies.

Authors:  Hans-Jürgen Bandelt; Anita Kloss-Brandstätter; Martin B Richards; Yong-Gang Yao; Ian Logan
Journal:  J Hum Genet       Date:  2013-12-05       Impact factor: 3.172

5.  Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Authors:  David K Simon; Nathan Pankratz; Diane K Kissell; Michael W Pauciulo; Cheryl A Halter; Alice Rudolph; Ronald F Pfeiffer; William C Nichols; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2010-04-01       Impact factor: 2.103

6.  Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells.

Authors:  M D'Aurelio; C Vives-Bauza; M M Davidson; G Manfredi
Journal:  Hum Mol Genet       Date:  2009-10-29       Impact factor: 6.150

Review 7.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

Review 8.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

9.  Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson's disease risk in a Polish PD cohort.

Authors:  Katarzyna Gaweda-Walerych; Aleksandra Maruszak; Krzysztof Safranow; Monika Bialecka; Gabriela Klodowska-Duda; Krzysztof Czyzewski; Jaroslaw Slawek; Monika Rudzinska; Maria Styczynska; Grzegorz Opala; Marek Drozdzik; Jeffrey A Canter; Maria Barcikowska; Cezary Zekanowski
Journal:  J Neural Transm (Vienna)       Date:  2008-09-23       Impact factor: 3.575

10.  Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia.

Authors:  Jaana Autere; Jukka S Moilanen; Saara Finnilä; Hilkka Soininen; Arto Mannermaa; Päivi Hartikainen; Merja Hallikainen; Kari Majamaa
Journal:  Hum Genet       Date:  2004-04-24       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.